DAX24.262 +0,2%ESt505.393 +0,3%Top 10 Crypto16,05 +0,9%Dow44.461 -0,4%Nas21.130 +0,2%Bitcoin102.684 +0,6%Euro1,1405 -1,2%Öl73,47 +1,0%Gold3.275 -1,6%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Novo Nordisk A3EU6F Heidelberger Druckmaschinen 731400 NVIDIA 918422 Rheinmetall 703000 Mercedes-Benz Group (ex Daimler) 710000 adidas A1EWWW Commerzbank CBK100 BYD A0M4W9 DroneShield A2DMAA RENK RENK73 Siemens Energy ENER6Y BASF BASF11 Deutsche Bank 514000 Lufthansa 823212 PayPal A14R7U
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Fed lässt Leitzins stabil: DAX schließt etwas fester -- US-Börsen schließen uneinheitlich -- Mercedes-Benz senkt Prognose -- D-Wave, DroneShield, Microsoft, Novo Nordisk, BYD, adidas, BASF im Fokus
Top News
Meta Platforms-Aktie schießt nach oben: Meta übertrifft alle Erwartungen Meta Platforms-Aktie schießt nach oben: Meta übertrifft alle Erwartungen
Microsoft-Aktie nähert sich Rekordhoch: Microsoft kann Umsatz- und Gewinnerwartungen deutlich schlagen Microsoft-Aktie nähert sich Rekordhoch: Microsoft kann Umsatz- und Gewinnerwartungen deutlich schlagen
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Ãœbersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Carlisle Companies Aktie

Handeln
Aktien-Sparplan anlegen
351,30 EUR -17,20 EUR -4,67 %
BMN
385,00 USD -24,00 USD -5,87 %
nachbörslich
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.15,87 Mrd. EUR

KGV20,32Div. Rendite1,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN871884

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS1423391002

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolCSL

Carlisle Companies Aktien News

DatumMeistgelesen
PR NewswireTavneos® (avacopan) included in updated EULAR recommendations for the management of AAV
PR NewswireCSL Opens New, State-of-the-Art Vaccine Research and Development Facility in Waltham, Massachusetts
PR NewswireThe Lancet Publishes Pivotal Phase 3 Data on CSL's First-in-Class Garadacimab for HAE
PR NewswireCSL's Phase 3 Study Shows First-In-Class Garadacimab Provides Patients with Significant HAE Attack Prevention with Monthly Dosing
PR NewswireCSL's HOPE-B Data Published in the New England Journal of Medicine, Demonstrating Efficacy and Durability of HEMGENIX® (etranacogene dezaparvovec-drlb)
PR NewswireBiotech Leader CSL Again Named Among America's Best Employers by Forbes
PR NewswireFirst Gene Therapy for Hemophilia B, CSL's HEMGENIX®, Approved by the European Commission
PR NewswireTavneos® (avacopan) approved in Australia for the treatment of ANCA-associated vasculitis
PR NewswireCSL Announces Next CEO & Managing Director
PR NewswireCSL Announces Next CEO & Managing Director
PR NewswireCSL Announces Next CEO & Managing Director
PR NewswireCSL Announces Next CEO & Managing Director
PR NewswireCSL Announces Next CEO & Managing Director
PR NewswireCSL Announces Closing of Global Collaboration and Licensing Agreement with Arcturus Therapeutics
PR NewswireCSL's Novel Gene Therapy HEMGENIX® (etranacogene dezaparvovec-drlb) Demonstrates Durable Protection and Sustained Factor IX Activity Levels for People Living with Hemophilia B at 24-Months Post-Tr...
PR NewswireU.S. Food and Drug Administration approves CSL's HEMGENIX® (etranacogene dezaparvovec-drlb), the first gene therapy for hemophilia B
PR NewswireMAS Gold Corp and Kitsaki Management Limited Partnership Sign Memorandum of Understanding
PR NewswireNext-Generation mRNA, Gene Therapy, Plasma Products, Monoclonal Antibodies, and Recent Acquisitions and Collaborations Highlight CSL R&D Day 2022
PR NewswireCSL Enters Licensing Agreement with Arcturus Therapeutics for Next Generation mRNA Vaccine Technology
PR NewswireCSL Plasma Expands in California with New Donation Centers to Collect Life-Saving Plasma
PR NewswireCSL Seqirus Announces U.S. Government Award to Manufacture and Clinically Assess Influenza A(H5N8) Pre-Pandemic Vaccine
PR NewswireCSL Announces Positive Preclinical Data for Self-Amplifying Messenger RNA (sa-mRNA) Influenza Vaccine Candidates
PR NewswireNew Canadian Surveys Highlight Influenza Education, Discussions with Healthcare Professionals, and Ease of Access as Critical to Supporting Vaccination Uptake
PR NewswireNew Canadian Surveys Highlight Influenza Education, Discussions with Healthcare Professionals, and Ease of Access as Critical to Supporting Vaccination Uptake
PR NewswireNew Data at OPTIONS XI Conference Highlight Burden of Seasonal Influenza on Health Systems and the Need for Increased Vaccination Rates
PR NewswireNew Real-World Data Presented at OPTIONS XI Show Cell-Based and MF59®-Adjuvanted Influenza Vaccines Can Reduce the Burden of Seasonal Influenza on Hospitals and Health Systems
PR NewswireCSL presents new research and development center in Marburg, Germany
PR NewswireCSL Plasma Provides Free Flu Vaccines to U.S. Plasma Donors
PR NewswireCarlisle TyrFil Announces its 2022 Initiative to Support Reforestation in Ontario, Canada, in Concert with American Forests
PR NewswireCSL Announces Positive Top-Line Phase 3 Results for Garadacimab as Preventive Treatment in Patients with Hereditary Angioedema (HAE)
PR NewswireCSL announces carbon emissions reduction targets
PR NewswireCSL announces carbon emissions reduction targets
PR NewswireCSL LAUNCHES NEW UNIFIED GLOBAL BRAND IDENTITY
PR NewswireCSL LAUNCHES NEW UNIFIED GLOBAL BRAND IDENTITY
PR NewswireCSL Plasma Reimagines Donor Experience With First Donations Completed on Innovative Plasma Collection Technology
ReutersFactbox: Potential candidates to replace hawk Lautenschlaeger on ECB board
ReutersPotential candidates to replace hawk Lautenschlaeger on ECB board
ReutersLagarde must smooth ECB feathers after top hawk quits
ReutersBankers hawk hedging as trade war hits China's yuan

Carlisle Companies News

Carlisle Companies News: auf dieser Seite finden Sie alle Carlisle Companies News und Nachrichten zur Carlisle Companies Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Carlisle Companies News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Carlisle Companies News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.